Breaking News
Get 50% Off 0
🏄 Grow your portfolio even on vacation with InvestingPro | Summer Sale 50% OFF
CLAIM SALE
Close

Beijing Biostar Pharmaceuticals Co Ltd (2563)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
8.07 +0.07    +0.88%
04:59:00 - Delayed Data. Currency in HKD
Type:  Equity
Market:  Hong Kong
ISIN:  CNE100006NB3 
  • Volume: 670,600
  • Bid/Ask: 8.07 / 8.10
  • Day's Range: 7.96 - 8.12
Beijing Biostar Pharmaceuticals 8.07 +0.07 +0.88%

Beijing Biostar Pharmaceuticals Co Ltd Company Profile

 
Get an in-depth profile of Beijing Biostar Pharmaceuticals Co Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

147

Equity Type

ORD

Beijing Biostar Pharmaceuticals Co., Ltd., a synthetic biology-driven biopharmaceutical company, engages in the research, development, manufacture, and commercialization of oncology products in the People’s Republic of China. The company develops Utidelone injection, a microtubule inhibitor for the treatment of advanced and neoadjuvant breast cancer, advanced non-small cell lung cancer, gastric and esophageal cancer, brain metastasis, solid tumors, and glioblastoma. It is also involved in the development of Utidelone capsule that is in Phase II/III clinical trials; Utidelone nanoformulation; and Utidelone antibody drug conjugate, as well as other active pharmaceutical ingredients, such as BG22, BG18, and BG44 in early development stages. The company develops its pharmaceutical products through its technology platforms, including combinatorial biosynthesis, microbial fermentation production, and microbial drug formulation development platforms. In addition, it provides medical consultation services. Beijing Biostar Pharmaceuticals Co., Ltd. was incorporated in 2002 and is headquartered in Beijing, China.

Contact Information

Address Building 3, Tower B, Yicheng Fortune Center Unit 1202B, 12/F
No. 22 Ronghua Middle Road Beijing Economic-Technological Development Area Beijing, 100176
China
Phone 86 10 6786 4938
Fax 86 10 6786 4938

Top Executives

Name Age Since Title
Simon Guan - - VP & Board Director
Li Tang 61 2002 Co-Founder, Chairperson, Chief Scientific Officer & Chief Marketing Officer
Rongguo Qiu 62 2002 Co- Founder, Vice-Chairperson, CEO & GM
Jin Guan 41 2023 Deputy GM & Executive Director
Jin Tang 69 2023 Non-Executive Director
Shufeng Zhang 56 2016 Chairperson of the Supervisory Committee
Cheng Zhang 49 2016 Deputy GM, VP & Executive Director
Chengang Ye 63 2025 Independent Non-Executive Director
Songdong Meng 54 2022 Independent Non-Executive Director
Rixiang Kong 48 2021 Employee Representative Supervisor & R&D Director
Quan Zhou 38 2016 Supervisor
Xuefen Dai 48 2025 Non-Executive Director
Shu Ming Shiu 55 2025 Independent Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

2563 Comments

Write your thoughts about Beijing Biostar Pharmaceuticals Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email